Daniel J. O'Connor, President and CEO at Ambrx Biopharma, Inc. (AMAM), sold 100,024 shares at $9.82 ($982K) on 2023-10-27, disclosed to the SEC on 2023-10-31.
Scheduled sale ($982k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.82 | 50,012 | $491K | 50.0% |
| 2 | $9.82 | 50,012 | $491K | 50.0% |
| Total | $9.82 avg | 100,024 | $982K | 100% |
| Filing → |
| ONCS | SELL | 2021-02-02 | $26K | — | Filing → |
| ONCS | SELL | 2020-11-03 | $12K | — | Filing → |
| ONCS | SELL | 2020-08-04 | $13K | — | Filing → |